Spiro compounds
US6803372B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2002 |
| Grant date | Oct 12, 2004 |
| Priority date | — |
| Expiry date | May 14, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the general formula (I): wherein Ar1 represents optionally substituted aryl or heteroaryl;n represents 0 or 1;T, U, V, and W each independently represent nitrogen atom or optionally substituted methine group, where at least two of them represent the said methine group;X represents methine or hydroxy substituted methine;Y represents an optionally substituted imino or oxygen atom are described and claimed. These novel spiro compounds are useful as neuropeptide Y receptor antagonists and as agents for the treatment of various kinds of cardiovascular disorders, central nervous system disorders, metabolic diseases and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.